SCHEMBL1666910

SCHEMBL1666910

CC1(C)CNC(=O)c2ccccc2O1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.55
ALDH1A1 P00352 3/20 0.47
PLA2G1B P04054 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
GSK3B P49841 1/20 0.38
MAPT P10636 4/20 0.37
IDO1 P14902 2/20 0.37
PARP10 Q53GL7 3/20 0.37
PARP11 Q9NR21 3/20 0.37
PARP1 P09874 2/20 0.37
PDPK1 O15530 1/20 0.37
MEN1 O00255 2/20 0.37
GLA P06280 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31395276 0.79 KDM4E (0.38) KDM4EALDH1A1PLA2G1BATG4BLMNA
SCHEMBL23160411 0.78 KDM4E (0.57) KDM4EALDH1A1CA9LMNAMAPT
SCHEMBL1666332 0.78 KDM4E (0.57) KDM4ETDP1GSK3BMAPTIDO1
SCHEMBL23175227 0.77 ALDH1A1 (0.43) KDM4EALDH1A1PLA2G1BATG4BCA12
SCHEMBL23175233 0.76 KDM4E (0.44) KDM4EALDH1A1LMNATDP1GSK3B
SCHEMBL1555141 0.74 GAA (0.40) KDM4EALDH1A1MAPTPARP1MEN1
SCHEMBL30303079 0.74 GAA (0.40) KDM4EALDH1A1MAPTPARP1MEN1
Hydrochloric Acid SCHEMBL31398582 0.73 ALDH1A1 (0.46) ALDH1A1PLA2G1BATG4BMAPTKMT2A
SCHEMBL1711500 0.73 ALDH1A1 (0.56) KDM4EALDH1A1PLA2G1BATG4BLMNA
SCHEMBL544297 0.73 ALDH1A1 (0.60) KDM4EALDH1A1MAPTGLANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024101965-A1 PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITOR AND DNA DAMAGE-INDUCING SUBSTANCE 에스케이바이오팜 주식회사 2024-05-16 WO claimed
US-20260137700-A1 PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITOR AND DNA DAMAGE-INDUCING SUBSTANCE SK BIOPHARMACEUTICALS CO LTD (KR) 2026-05-21 US disclosed
WO-2025031842-A1 NEW SUBSTITUTED BENZOXAZEPINE PICOLINONITRILE COMPOUNDS FOR COMBATTING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2025-02-13 WO disclosed
US-20240051951-A1 BICYCLIC COMPOUND AND USE THEREOF SK BIOPHARMACEUTICALS CO., LTD. (KR) 2024-02-15 US disclosed
US-11725001-B2 Bicyclic compound and use thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2023-08-15 US disclosed
US-20220402902-A1 BICYCLIC COMPOUND AND USE THEREOF SK BIOPHARMACEUTICALS CO., LTD. 2022-12-22 US disclosed
EP-4039686-A1 BICYCLIC COMPOUND AND USE THEREOF SK Biopharmaceuticals Co., Ltd. (KR) 2022-08-10 EP disclosed
WO-2021066578-A1 BICYCLIC COMPOUND AND USE THEREOF 에스케이바이오팜 주식회사 2021-04-08 WO disclosed
EP-2314583-B1 NITROGENATED HETEROCYCLIC DERIVATIVE, AND AGRICULTURAL OR HORTICULTURAL BACTERICIDAL AGENT NIPPON SODA CO (JP) 2015-02-25 EP disclosed
US-8557738-B2 Nitrogen-containing heterocyclic derivative and fungicide for agricultural and horticultural use NIPPON SODA CO., LTD. (JP) 2013-10-15 US disclosed
US-20110136782-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND FUNGICIDE FOR AGRICULTURAL AND HORTICULTURAL USE NIPPON SODA CO., LTD (JP) 2011-06-09 US disclosed
EP-2314583-A1 NITROGENATED HETEROCYCLIC DERIVATIVE, AND AGRICULTURAL OR HORTICULTURAL BACTERICIDAL AGENT Nippon Soda Co., Ltd. (JP) 2011-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402902-A1 BICYCLIC COMPOUND AND USE THEREOF PRMT5, PRMT6, PRMT1 KDM4E 44/4885ALDH1A1 3781/4885PLA2G1B 3478/4885
US-20260137700-A1 PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITOR AND DNA DAMAGE-INDUCING SUBSTANCE PRMT5, PRMT1, PRMT6 KDM4E 327/4885ALDH1A1 3485/4885PLA2G1B 2240/4885
US-20240051951-A1 BICYCLIC COMPOUND AND USE THEREOF PRMT5, PRMT6, PRMT1 KDM4E 44/4885ALDH1A1 3781/4885PLA2G1B 3478/4885
US-11725001-B2 Bicyclic compound and use thereof PRMT5, PRMT6, PRMT1 KDM4E 44/4885ALDH1A1 3781/4885PLA2G1B 3478/4885
US-20110136782-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND FUNGICIDE FOR AGRICULTURAL AND HORTICULTURAL USE CBR3, NOS1, CBR1 KDM4E 1580/4885ALDH1A1 2698/4885PLA2G1B 4608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.